Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Alexander

Showing results (901-910 of 1,212) with videos related to

Pageof 122
Sort By:
Open Heart|February 17, 2022
Impact of prior oral anticoagulant use and outcomes on patients from secondary analysis in the AUGUSTUS trialRobert C Welsh, Payam Dehghani, Renato Lopes, et al.
Critical Care Medicine|October 21, 2010
Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarctionJonathan P Piccini, Phillip J Schulte, Karen S Pieper, et al.
Journal of the American College of Cardiology|March 25, 2014
Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical OutcomesElaine M Hylek, Claes Held, John H Alexander, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 6, 2003
Changes in CD4+ T-cell differentiation phenotype during structured treatment interruption in patients with chronic HIV-1 infectionThomas H Alexander, Gabriel M Ortiz, Melissa F Wellons, et al.
The American Journal of Cardiology|May 21, 2005
Association of height with outcomes in patients with acute myocardial infarction receiving reperfusion therapyRajendra H Mehta, Robert M Califf, Jyotsna Garg, et al.
British Journal of Pharmacology|November 12, 2019
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: TransportersStephen P H Alexander, Eamonn Kelly, Alistair Mathie, et al.
Circulation|August 30, 2016
Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial FibrillationJonas Oldgren, Ziad Hijazi, Johan Lindbäck, et al.
Heart (British Cardiac Society)|September 17, 2020
Premature permanent discontinuation of apixaban or warfarin in patients with atrial fibrillationAnthony P Carnicelli, Sana M Al-Khatib, Denis Xavier, et al.
European Heart Journal|February 28, 2016
The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillationZiad Hijazi, Johan Lindbäck, John H Alexander, et al.
The Annals of Thoracic Surgery|September 26, 2018
Longitudinal Changes in Regional Cerebral Perfusion and Cognition After Cardiac OperationPatrick J Smith, Jeffrey N Browndyke, Zachary A Monge, et al.
Pageof 122

Showing results (901-910 of 1,212) with videos related to

Sort By:
Pageof 122
Open Heart|February 17, 2022
Impact of prior oral anticoagulant use and outcomes on patients from secondary analysis in the AUGUSTUS trialRobert C Welsh, Payam Dehghani, Renato Lopes, et al.
Critical Care Medicine|October 21, 2010
Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarctionJonathan P Piccini, Phillip J Schulte, Karen S Pieper, et al.
Journal of the American College of Cardiology|March 25, 2014
Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical OutcomesElaine M Hylek, Claes Held, John H Alexander, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 6, 2003
Changes in CD4+ T-cell differentiation phenotype during structured treatment interruption in patients with chronic HIV-1 infectionThomas H Alexander, Gabriel M Ortiz, Melissa F Wellons, et al.
The American Journal of Cardiology|May 21, 2005
Association of height with outcomes in patients with acute myocardial infarction receiving reperfusion therapyRajendra H Mehta, Robert M Califf, Jyotsna Garg, et al.
British Journal of Pharmacology|November 12, 2019
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: TransportersStephen P H Alexander, Eamonn Kelly, Alistair Mathie, et al.
Circulation|August 30, 2016
Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial FibrillationJonas Oldgren, Ziad Hijazi, Johan Lindbäck, et al.
Heart (British Cardiac Society)|September 17, 2020
Premature permanent discontinuation of apixaban or warfarin in patients with atrial fibrillationAnthony P Carnicelli, Sana M Al-Khatib, Denis Xavier, et al.
European Heart Journal|February 28, 2016
The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillationZiad Hijazi, Johan Lindbäck, John H Alexander, et al.
The Annals of Thoracic Surgery|September 26, 2018
Longitudinal Changes in Regional Cerebral Perfusion and Cognition After Cardiac OperationPatrick J Smith, Jeffrey N Browndyke, Zachary A Monge, et al.
Pageof 122